Psychocutaneous disease: Pharmacotherapy and psychotherapy

Helena Kuhn; Constance Mennella; Michelle Magid; Caroline Stamu-O'Brien; George Kroumpouzos

doi:10.1016/j.jaad.2016.11.021

Psychocutaneous disease: Pharmacotherapy and psychotherapy

Helena Kuhn
, Constance Mennella
, Michelle Magid
, Caroline Stamu-O'Brien
, George Kroumpouzos

Research output: Contribution to journal › Review article › peer-review

36 Scopus citations

Abstract

Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

Original language	English
Pages (from-to)	795-808
Number of pages	14
Journal	Journal of the American Academy of Dermatology
Volume	76
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2016.11.021
State	Published - May 2017
Externally published	Yes

Keywords

antidepressant
antipsychotic
cognitive-behavioral therapy
drug
management
pruritus
psychocutaneous
psychotherapy

Access to Document

10.1016/j.jaad.2016.11.021

Cite this

@article{d5fe867ed3e64b1e843acf99acbe26ea,

title = "Psychocutaneous disease: Pharmacotherapy and psychotherapy",

abstract = "Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.",

keywords = "antidepressant, antipsychotic, cognitive-behavioral therapy, drug, management, pruritus, psychocutaneous, psychotherapy",

author = "Helena Kuhn and Constance Mennella and Michelle Magid and Caroline Stamu-O'Brien and George Kroumpouzos",

note = "Publisher Copyright: {\textcopyright} 2016 American Academy of Dermatology, Inc.",

year = "2017",

month = may,

doi = "10.1016/j.jaad.2016.11.021",

language = "English",

volume = "76",

pages = "795--808",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Psychocutaneous disease

T2 - Pharmacotherapy and psychotherapy

AU - Kuhn, Helena

AU - Mennella, Constance

AU - Magid, Michelle

AU - Stamu-O'Brien, Caroline

AU - Kroumpouzos, George

PY - 2017/5

Y1 - 2017/5

N2 - Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

AB - Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

KW - antidepressant

KW - antipsychotic

KW - cognitive-behavioral therapy

KW - drug

KW - management

KW - pruritus

KW - psychocutaneous

KW - psychotherapy

UR - https://www.scopus.com/pages/publications/85017528880

U2 - 10.1016/j.jaad.2016.11.021

DO - 10.1016/j.jaad.2016.11.021

M3 - Review article

C2 - 28411772

AN - SCOPUS:85017528880

SN - 0190-9622

VL - 76

SP - 795

EP - 808

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -

Psychocutaneous disease: Pharmacotherapy and psychotherapy

Abstract

Keywords

Access to Document

Fingerprint

Cite this